Dr Kenneth Micklethwaite
The University of Sydney (NSW)
$332,077
2015 - 2017
The Research
Helping the immune system to target and destroy multiple myeloma cells.
share
.svg)
Gene modified T cells expressing a chimeric antigen receptor for a kappa light chain antigen to treat multiple myeloma
Myeloma
NSW
